key: cord-0699374-0xezd87r
authors: Rahayatri, Tri Hening; Amaliyah, Rizky; Putri, Nandita Melati; Puspaningtyas, Niken Wahyu; Karyanti, Mulya Rahma; Hendarto, Aryono
title: Omphalopagus conjoined twins separation during coronavirus disease-19 pandemic era: A case report
date: 2021-06-29
journal: Int J Surg Case Rep
DOI: 10.1016/j.ijscr.2021.106150
sha: caeebd3d3ebaeaeffb23284ab802f15b3365cd69
doc_id: 699374
cord_uid: 0xezd87r

INTRODUCTION AND IMPORTANCE: Conjoined twin is a rare congenital anomaly characterized by a fusion of certain anatomical structures. Coronavirus-19 (COVID-19) is a new emerging infectious respiratory disease affecting worldwide and potentially leads to acute respiratory distress (ARDS) in children. COVID-19 has reconstructed the healthcare system, including surgical care and decision-making. CASE PRESENTATION: Herein we describe a surgical separation of 2.5 months old omphalopagus conjoined twins, with one of them (Baby A) presenting COVID-19-associated respiratory distress, as well as the challenges faced during the preparation and the execution of the complex surgical procedure. CLINICAL DISCUSSION: Baby A underwent antiviral therapy, oxygen supplementation, and ventilation in the ICU, while baby B remained stable and confirmed negative for SARS-CoV-2. The separation surgery was conducted after baby A had become clinically stable. Defect closure and reconstruction were accomplished. At one week follow-up, Baby A died of lung infection, while baby B remained well after one year. CONCLUSION: The complexity of surgical separation requires careful planning by a multidisciplinary team. Surgical separation of conjoined twins during the pandemic era has not been reported much in the literature, more reports are required to provide further insight.

Conjoined twins are monozygotic identical twins that share a physical fusion. Conjoined twinning is a rare anomaly, with an incidence of 1.5/100.000 to 1/500.000 births in western countries. 1, 2 Fusion at the anterior thorax and abdomen, including omphalopagus being the most common (70%). 3 

Health Organization (WHO) on 11 March 2020. In situations where surgical intervention is required for COVID-19 patients with sequelae, a poor postoperative outcome is expected. In addition to that, the increased risk of COVID-19 transmission to healthcare providers (HCP) prompts prioritizing urgent cases and postponing the elective ones. 4 Herein, we report the first case of omphalopagus conjoined twins during the COVID-19 pandemic, with one of the twins diagnosed with a COVID-19 infection, along with the difficulties encountered in the preoperative, intraoperative, postoperative management, and the preventive measures of HCP transmission at the beginning of the COVID-19 pandemic era.

This case report has been reported in line with the SCARE Criteria. 5 J o u r n a l P r e -p r o o f Journal Pre-proof

Omphalopagus female conjoined twins were referred to our hospital at the age of 2.5 months old ( Figure 1 ). One baby (baby A) presented with sepsis and acute respiratory dysfunction syndrome (ARDS) due to COVID-19, confirmed by bronco-alveolar lavage, manifesting shortness of breath. At the first week of hospitalization, baby A was lethargic, underwent recurrent desaturation, and had respiratory acidosis. Although a Computed tomography scan (CT-scan) showed ground-glass opacity and multiple consolidations in both babies, baby B's clinical appearance was well and tested negative with COVID-19 polymerase chain reaction (PCR).

Written informed consent was obtained from the patient for publication of this case report and accompanying images.

Imaging from CT scan showed pericardium, sternum, and liver fusion, whereas a non-ionic contrast meal evaluation showed no bowel fusion ( Figure 2 ). The fusion was 9 centimeter (cm) in latero-lateral, and 15 cm in cranio-caudal direction. Fusion and fenestration were not evident in the heart, but cardiomegaly was noted in both babies. Part of Baby A's heart herniated into Baby B's thoracic cage. Atelectasis was present in both babies, however, pulmonary hypertension did not occur. In the liver, a connection was identified between the left portal vein of baby A and the left portal vein of baby B, with an arterioportal shunt. Magnetic resonance imaging (MRI) showed no fusion in the biliary system. Eventually, a conventional ventilator and high-frequency oscillation ventilation (HFOV) were used due to ARDS. Baby B remained stable and did not require any oxygen therapy. On the 10 th day of treatment, the PCR test of both showed negative.

During the two months in the ICU, Baby A developed recurrent pneumonia, ventilator weaning difficulty, and sepsis that escalated to septic shock. Three months post-hospitalization, the ventilator was weaned to non-invasive support for baby A and baby B received an oxygen nasal cannula 2 litres per minute J o u r n a l P r e -p r o o f Journal Pre-proof (lpm) . There was no fever, the antibiotic treatment achieved infection control. Both babies were in stable condition and the plan to perform the separation surgery proceeded. The operation was performed by a multidisciplinary team and was completed in 13 hours by pediatric, cardiothoracic, and plastic surgeons. The intraoperative findings in the chest cavity were underdeveloped sternum and costae, with a defect in the diaphragm. Baby A did not have a sternum and the pericardial tissue required dissection for separation.

Hepatectomy was performed Using Cavitron Ultrasonic Surgical Aspirator (CUSA  ), whereas bleeding control utilized monopolar and bipolar cautery, surgical clips, and suture. A portal vein crossing between both livers was carefully identified and ligated. We performed a hanging maneuver using a small Nelaton catheter placed behind the liver.

In baby B, Cardiothoracic surgeons performed reconstruction of the pericardium using a Gore-Tex  patch and plates were placed to attach the diaphragm to the costae to allow diaphragm movement for adequate respiration. The abdominal cavity was closed using a mesh, followed by the defect closure utilizing a flap.

The defect dimension on baby A was 15x25 cm after separation surgery ( Figure 3 ). Due to unstable hemodynamics, the skin closure in baby A was postponed. POD+3 of separation surgery, baby A was scheduled for closure of the defect. A defect on baby B was 9x15 cm (Figure 4 ). Bilateral keystone design perforator island flap from the lateral side of the defect was designed around the perforator which was identified using hand-held Doppler ultrasound. We used dynamic sutures for an expansion effect on the keystone flap. Baby A's general condition improved, hence we performed surgery to cover Baby A experienced bacterial septicemia, severe wound infection and underwent multiple debridement procedures whilst Baby B had no significant postoperative complication. Baby A was discharged on POD+66 after defect closure. Baby B was discharged one month after separation surgery.

One week following discharge, baby A developed a lung infection and high fever, which caused mortality while she was treated at another hospital. Baby B's condition remained well at a one-year follow-up.

Conjoined twins were referred to our hospital due to sepsis with severe COVID-19-associated The issue was not on the technicality, as our team has experience in separation surgery of conjoined twins for more than thirty years. The presence of a pandemic was a contributing challenge. With minimal resources and infrastructure in our country, we struggle to offer the best treatment for COVID-19 patients.

The vital points that affect the decision to perform surgical separation lie in the mortality and morbidity of the outcome. The surgeons agreed to perform the surgical separation when a stable condition in both babies was well-established and infants were aged around 3-4 months old with an accumulated weight over 10 kilograms, along with a negatively confirmed SARS-CoV-2 following 3 months from the initial infection.

In the absence of COVID-19 infection, the timing of surgery remains controversial and varies between institutions. A delay of a few months yields a higher chance of survival. Without an indication for early separation, the surgery is ideally performed at the age of 3 months, allowing detailed investigations and a careful wound closure plan. 6 A separation surgery that is delayed until the age of 10 months old and further instigates a psychosocial issue, as it interferes with the developmental aspect. 1, 7 High-frequency oscillation ventilation (HFOV) was administered for one of the twins at the occurrence of ARDS and presented a good outcome, despite the finding of a systematic review and meta-analysis on the failure of HFOV to reduce hospital and 30-day mortality due to ARDS compared to mechanical ventilation. 8 Ventilation intervention recommended by Kache et al. 9 for children with COVID-19 is mechanical ventilation, as HFOV is not the choice for routine application but may be considered in selected cases, although these statements have insufficient evidence. 9

A twin separation requires accurate determination of anatomy and vascular supply. Evaluation of vascular shunts and cross-circulation is important for anesthetic management, as shared blood vessel ligation and separation may be necessary during surgery to prevent hypovolemic shock due to loss of blood volume. 10 Once the entire system has been evaluated and vascular territories have been established, the multidisciplinary team reviews the information to plan separation.

COVID-19 infection control and prevention were compliant with the guidelines set by the Centers for Disease Control and Prevention (CDC). As the surgery involved the opening of the thoracic cavity, we utilized aerosol PPE including an N95 mask, goggles, disposable gowns, and gloves. All operating theatre (OT) staff stepped up infection control measures and conducted N95 mask fitting sessions. Appropriate PPE utilization, maintenance of a pre-determined surgical team, and minimizing surgical traffic were vital in preserving equipment and limiting HCP exposure. Reducing OT staff and entering and exiting were strictly applied to avoid transmission. 11

The separation of a conjoined liver is a highly complex operation carrying risks for hemorrhage, vascular thrombosis, and biliary complications. To minimize blood loss during hepatic parenchymal dissection, we incorporated conventional techniques with CUSA. Staying at the cleavage line facilitated both a safe and relatively dry dissection. Al-Rabeeah et al. 12 suggested that applying a large Penrose drain circumferentially helped identify the cleavage line.

Intrahepatic portal vein crossings joined the liver parenchyma. We performed a hanging maneuver circumferentially, as described by Belghitti et al. 13 ; encircling the portal pedicle after carefully dissecting across the anterior surface of the intrahepatic IVC, elevating the liver from the anterior surface of the IVC. Vessel loop or Penrose drain used to elevate the hepatic parenchyma provided adequate exposure and effective hemostasis if required.

Chest and abdominal wall closure present a challenge in omphalopagus twins. Body wall defect coverage post-separation was accomplished using prosthetic materials and preoperative tissue J o u r n a l P r e -p r o o f expansion. Preoperative tissue expansion requires time, but time for tissue expansion was inadequate.

There was an increased risk of infection in the tissue expander. Protrusion of the heart predominantly posed closure difficulty, similar to the case of thoracic ectopia cordis. Autologous tissue coverage with various methods typically produces excessive compression of the heart, limiting cardiac output by impeding cardiac filling or kinking great vessels. The thoracic cavity of Baby B was bigger than baby A.

Pericardium reconstruction used Gore-Tex  soft tissue patch. The diaphragm and the entire anterior costaes were fixed to the miniplate. The heart apex of Baby B and Baby A projected approximately 3 cm and 5 cm above the chest wall, respectively. The liver of Baby A projected 10 cm above the abdominal wall.

Chest and abdominal wall coverage of baby B were successful with Proceed ® surgical mesh and bilateral keystone design perforator island flap, and coverage was left open. The closure of baby A was delayed due to inadequate soft tissue coverage and hemodynamic instability. Bioprosthetic materials are better than permanent synthetic materials for gradual remodeling into autologous tissue to adapt to body growth. Proceed ® mesh had three distinct materials, providing a bioresorbable layer that physically separates polypropylene mesh from visceral organs absorbed within 6 months.

Rehabilitation was facilitated before surgical separation to increase overall health, strength, and endurance to withstand surgical demands. Respiratory rehabilitation for Baby A with post-ARDS due to COVID-19 infection was essential, as mentioned in the guidelines by WHO. Rehabilitation programs from post-acute to long-term are tailored according to patient's needs.

Omphalopagus conjoined twins were successfully separated with a multidisciplinary approach during the COVID-19 pandemic. A well-planned preparation, operation timing, and procedure were paramount. Postoperative management involving a multidisciplinary team to obtain the best outcome for patient survival.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

The following information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories, then this should be stated.

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.

The authors declare no conflict of interest.

All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.

No fundings for research are declared.

Research studies involving patients require ethical approval. Please state whether approval or exemption has been given, name the relevant ethics committee and the state the reference number for their judgement. Please give a statement regarding ethnical approval that will be included in the publication of your article, if the study is exempt from ethnical approval in your institution please state this.

Written informed consent was obtained from the patient for publication of this case report and J o u r n a l P r e -p r o o f accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Studies on patients or volunteers require ethics committee approval and fully informed written consent which should be documented in the paper.

Authors must obtain written and signed consent to publish a case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".

Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions, the Editor in Chief must be made aware of all such conditions. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Please specify the contribution of each author to the paper, e.g. study concept or design, data collection, data analysis or interpretation, writing the paper, others, who have contributed in other ways, should be listed as contributors.

J o u r n a l P r e -p r o o f 

Hepatic separation of conjoined twins: Operative technique and review of three-dimensional model utilization

The surgical principles of conjoined twin separation

Conjoined twins-thoraco-omphalopagus (type A). BJR Case Rep

COVID-19: What are the challenges for NHS surgery?

The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines

Experience in the management of conjoined twins. The British journal of surgery

Conjoined twins: twenty years' experience at a reference center in Brazil

High-frequency oscilatory ventilation versus conventional ventilation for acute respiratory distress syndrome (Review)

COVID-19 PICU guidelines: for high-and limitedresource settings

Imaging in the Preoperative Assessment of Conjoined Twins

Ten Ways Healthcare Systems Can Operate Effectively during the COVID-19 Pandemic

Hepatobiliary anomalies in conjoined twins

Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization

Not commissioned, externally peer-reviewed J o u r n a l P r e -p r o o f

In accordance with the Declaration of Helsinki 2013, the Editors of IJS Case Reports require that reports that are 'First in Man' studies should be registered prospectively and failing that retrospectively. There are many places to register your First in Man case report:• Clinicaltrials.gov -for all human studies -free • Chinese Clinical Trial Registry chictr.org.cn -for all human studies -free • Researchregistry.com -for all human studies -charge • ISRCTN.com -for all human studies -charge • There are many national registries approved by the UN that can be found here Elsevier does not support or endorse any registry.

The Guarantor is the one or more people who accept full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish